LONDON, Sept 19 (Reuters) - Canada’s Cangene Corp. (CNJ.TO: Quote, Profile, Research) has been awarded a C$17 million (US$14.4 million) contract by the British government, with UK-based vaccine specialist Acambis Plc (ACM.L: Quote, Profile, Research) acting as sales agent.
